Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
2020 Full year and fourth quarter results announcement
We will announce our full year and fourth quarter 2020 results at 12:00 GMT, 07:00 EST on Wednesday 3 February 2021.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, Iain Mackay, CFO, and Dr Hal Barron, Chief Scientific Officer and President of R&D, at 14:00 GMT, 09:00 EST.